**PHARMACISTS' ADVICE AND SUPPORT SERVICE** CCNI NUMBER - NIC101811 PERIOD FROM 01/06/2024 TO 31/05/2025 

|**STATEMENT OF RECEIPTS AND PAYMENTS**|**STATEMENT OF RECEIPTS AND PAYMENTS**||||
|---|---|---|---|---|
||||**Year to**|**Year to**|
||**Unrestricted **|**Restricted**|**May-25**|**May-24**|
||**Funds**|**Funds**|**TOTAL**|**TOTAL**|
|**Receipts**|**£**|**£**|**£**|**£**|
|Dividend on investments|35,912|-|**35,912**|11,208|
|Donations & Legacies|-|-|**-**|3,500|
|Interest|-|-|**-**|2,192|
|Sale of Fixed Asset|-|-|**-**|255,908|
|Gain on investment|35,810|-|**35,810**|-|
|**Total Receipts**|**71,721**|**-**|**71,721**|**272,808**|
|**Payments:**|||||
|Bank Fees|100|-|**100**|-|
|IT & Subscriptions|306|-|**306**|-|
|Grants|2,000|-|**2,000**|18,650|
|Loans|7,000|-|**7,000**|-|
|Counselling|8,090|-|**8,090**|-|
|Accountancy Fees|3,900|-|**3,900**|-|
|Telephone|158|-|**158**|-|
|Travel|228|-|**228**|-|
|General|51|-|**51**|-|
|Governance costs|-|-|**-**|10,547|
|Other costs|-|-|**-**|7,615|
|Investment management costs|6,172|-|**6,172**|4,480|
|Purchase of Investments|-|-|**-**|225,480|
|Salaries|8,012|-|**8,012**|-|
|**Total Payments:**|**36,018**|**-**|**36,018**|**266,772**|
|**Net receipts / (payments)**|35,703|-|**35,703**|6,036|
|**Transfers to / (from) funds**|-|-|**-**|-|
|**Surplus / (deficit) for the year**|35,703|-|**35,703**|6,036|
|**Reconciliation 31.05.25**|||||
|Cash at bank & in hand 31.05.24|21,744|-|**21,744**|15,708|
|Surplus / (deficit) for this year end|35,703|-|**35,703**|6,036|
|Cash at bank & in hand 31.05.25|**57,447**|**-**|**57,447**|**21,744**|



The statement of receipts and payments includes all gains and losses recognised in the year. All incoming resources and resources expended derive from continuing activities. 

## **PHARMACISTS' ADVICE AND SUPPORT SERVICE** CCNI NUMBER - NIC101811 PERIOD FROM 01/06/2024 TO 31/05/2025 

## **STATEMENT OF ASSETS AND LIABILITIES** 

||Unrestricted|Restricted|**Total**|Total|
|---|---|---|---|---|
|**Funds Reconciliation**|Funds|Funds|**2025**|2024|
||£|£|**£**|£|
|Cash at bank & in hand 31.05.24|21,744|-|**21,744**|15,708|
|Surplus / (deficit) for this year end|35,703|-|**35,703**|6,036|
|**Cash at bank & in hand 31.05.25**|57,447|-|**57,447**|21,744|
||Unrestricted|Restricted|**Total**|Total|
|**Bank & Cash Balances**|Funds|Funds|**2025**|2024|
||£|£|**£**|£|
|Cash at Bank|14,602|-|**14,602**|19,448|
|Depoist Account|42,845|-|**42,845**|2,296|
||57,447|-|**57,447**|21,744|
||Unrestricted|Restricted|**Total**|Total|
|**Assets**|Funds|Funds|**2025**|2024|
||£|£|**£**|£|
|Evelyn Portfolio Investments|479,203|-|**479,203**|525,326|
||479,203|-|**479,203**|525,326|
||Unrestricted|Restricted|**Total**|Total|
|**Liabilities**|Funds|Funds|**2025**|2024|
||£|£|**£**|£|
|Nil|-|-|**-**|-|
||-|-|**-**|-|



The financial statements were approved by the board Trustees on 10/03/2026 and were signed on their behalf by: 

Sheelin McKeagney Chair of the Board of Trustees, PFNI 

Glynis McMurty Chair of PASS Committee 

**PHARMACISTS' ADVICE AND SUPPORT SERVICE** CCNI NUMBER - NIC101811 PERIOD FROM 01/06/2024 TO 31/05/2025 

## **NOTES TO THE ACCOUNTS (CONTINUED)** 

## **1 Independent examiner's remuneration** 

The independent Examiner's remuneration amounts to an Independent Examination fee of £720. 

## **2 Post-Balance Sheet Events** 

None. 

## **3 Related Parties** 

The Charity does not have any related parties. 

## **4 Trustees remuneration & expenses** 

During the year, no Trustees received any remuneration (2024 - £NIL). 

During the year, no Trustees received any benefits in kind (2024 - £NIL). 

During the year, no Trustees received any reimbursement of expenses (2024 - £NIL).